Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 17 Next »

We are planning on holding the Friday event at the Fall Meetings in Baltimore.  We will be using new functionality available through David Hay in his "Conman" tool. 

The video provides more information regarding the tool.  Please review it prior to attending the event.  We will be running the tracks as listed below. 

Clinician on FHIR Tracks

  • create accounts on

Track 1

Care Coordination

    Lead: Emma Jones     

    Use case: Chronic Kidney Disease Use Case, 

             FHIR Resources: Care Plan and Care Team Workflow   

    Use Case:  Care Plan Review

Care Plan as a whole and individual care plan components need to be reviewed periodically (scheduled and adhoc) to ensure that health concerns, goals, interventions defined for managing patient's conditions are appropriate over time, and that the goals are met and identified health concerns are addressed/resolved adequately.

The current CarePlan resource lacks structure(s) required to support reviews as required.

It is proposed that the FHIR VerificationResult Resource should be assessed/considered for its fitness-for-purpose/adequacy to support care plan reviews.

Resources involved: Required = Care plan, Care Team, clinicalImpression; for consideration/evaluation = VerificationResult resource 

Scenario description:

Betsy Johnson has Type 2 DM diagnosed 20 years ago and started to develop chronic kidney disease (CKD) about 10 years ago. Her CKD is managed by a multi-disciplinary nephrology care team which is led by Dr Vince Jones, the Chief Nephrologist. the care team instantiated a CKD care plan to manage Betsy's chronic renal condition. 

Betsy's diabetes condition is managed by her Primary Care Physician. Her chronic renal condition is well managed and considered as relatively stable. She is seen by the nephrology care team every 2 monthly. Her CKD care plan is reviewed and intervention activities adjusted in accordance to her clinical assessment results (clinicalImpression)



Track 2

Emergency Care

     Leads: Laura Heermann and Jim McClay

     Use Case:  Screenings done during ED visit

     FHIR Resources: Questionnaire, Questionnaire Response.  

     Scope:  Entering the data for the answers to the questions contained on the screening tools such as PHQ9, Seatbelt use, Tobacco use, Alcohol use, ....

Track 3


Lead: Melva Peters, John Hatem

John Hatem email reply: will be at the event (no further details provided)

Use Case:

FHIR Resources:


Track 4

Clinical Impressions

    Lead: Stephen Chu, Rob Hausam 

    Use Case: (Stephen working on the use case/storyboard)

Betsy Johnson Storyboard


History: Betsy Johnson, a 60 yo female patients with medical history of Type 2 diabetes, hypertension, hyperlipidema 

On October 5, 2018 she attended a routine follow-up medical appointment at her Primary Care Provider's (Dr John Carlson) clinic 

Betsy complained that recently she felt a bit more tired than usual, otherwise, things seemed to be nothing remarkable

Dr Carlson reviewed Betsy's last blood work, which indicated that her eGFR was elevated beyond the normal reference range. A spot urine dipstick test revealed urine protein = 1+. Dr Carlson requested a repeat of eGFR and spot urine albumin-to-creatinine (ACR) ratio test, and told Betsy to return next week for a detailed clinical assessment on Betsy and documented the process and outcome

Clinical assessment/impression:
      • Code/description: renal/CKD assessment (no SNOMED code available)
      • Subject: Betsy Johnson; female, age 60
      • Context: PCP encounter
      • EffectiveDateTime (of clinical assessment): October 5, 2018
      • Date (documentation date): October 5, 2018
      • Investigation:
        • Reference - Observation: weight = 167 pound (75kg); height = 64 inches (162.5cm); BMI = 28.2 (overweight); BP = 148/90
        • Diagnostic report: eGFR = 62 ml/min/1.73 sq.metre; ACR = 68mg/g (7,68mg/mmol)
      • Protocol:
      • Summary
      • Finding
        • Reference - Condition:
      • PrognosisCodeableConcept
      • prognosisReference
        • Reference - Risk
      • Supporting information
      • Note

    FHIR Resources:  Clinical Impression, Condition, Allergy/Intolerance. diagnostic request, diagnostic reports


  • No labels